{"id":8364,"date":"2023-11-01T10:31:51","date_gmt":"2023-11-01T10:31:51","guid":{"rendered":"https:\/\/medical.ezag.com\/?post_type=insight&p=8364"},"modified":"2026-01-22T11:43:03","modified_gmt":"2026-01-22T11:43:03","slug":"illuminating-innovation-q2-2023","status":"publish","type":"insight","link":"https:\/\/medical.ezag.com\/en\/insights\/illuminating-innovation-q2-2023\/","title":{"rendered":"Illuminating Innovation \u2013 Q2\/2023"},"content":{"rendered":"
\n\t\t\t
\n\t\t\t
\n\t\t\t
\n\t\t\t
\n\t\t\t NOV<\/span>\n\t\t\t 1<\/span>\n\t\t\t <\/div>\n\t\t\t Nuclear Medicine<\/span>\n\t\t\t
<\/div>\n\t\t\t

Illuminating Innovation \u2013 Q2\/2023<\/h1>\n\t\t\t

Another quarter full of interesting publications involving our products. Check out this recent list of open access publications involving our products!

Once again, we went through the open access articles out there and gathered the ones mentioning our lab devices or radionuclides.

You want to be on the list next time? Reach out to us and let us know about your work!<\/p>\n\t\t\t <\/div>\n\t\t\t <\/div>Two people working with a Galliapharm\u00ae with EluGen<\/div>\n\t\t\t<\/section>\n\t\n\n\n

<\/p>\n\n\n

\n
\n
\n

Introduction<\/h2>\n
\n\n

In the ever-evolving landscape of scientific research and healthcare, our commitment to innovation continues to shine. For years, we have been at the forefront, delivering radionuclides, radiopharmaceuticals, radiosynthesizers, and quality control equipment to institutions worldwide. Today, a growing network of clinics and research facilities around the globe entrusts our products for their groundbreaking work.<\/p>\n\n\n

Inclusion criteria<\/p>

Most articles are open access articles. We search open access databases for new publications every quarter. If we identify one of our products in an article, it is added to the list.
If you want to have your work listed here, whether it be open access or not, make sure to contact us at marketing.medical@ezag.de<\/strong><\/p>\n <\/div>\n\t\n\n\n

In this latest edition, we once again turn the spotlight on the remarkable accomplishments of these institutions. We’ve combed through the second quarter of 2023 to curate a fresh selection of publications where our products have played an integral role. Join us as we delve into these recent successes and the impact of our solutions in the field.<\/p>\n

If you’ve missed out on the first one, make sure to check it out here<\/a>!<\/p>\n\n\n\n\t\t

<\/div>\n\t\n<\/section>\t\n\t\t\n\n

Publications Q2 \/ 2023<\/h2>\n
\n\n

The publications are categorized by their field of medical application and sorted by their online publishing date (descending).<\/p>\n

CARDIOLOGY<\/strong><\/h3>\n

68<\/sup>Ga-labeled WVP peptide as a novel PET probe for molecular biological diagnosis of unstable thoracic aortic aneurysm and early dissection: an animal study<\/a><\/strong>
Jun 12, 2023 | Lu X et al.\u00a0
Flow-Count<\/a> used for HPLC analysis of [68<\/sup>Ga]Ga-DOTA-WVP<\/p>\n

GASTROENTEROLOGY<\/strong><\/h3>\n

New Radiolabeled Exendin Analogues Show Reduced Renal Retention<\/a><\/strong>
Jun 02, 2023 | Joosten L et al.
GalliaPharm\u00ae<\/sup><\/a> used to radiolabel Exendin-4 analogues with [68<\/sup>Ga]Gallium<\/p>\n

HEMATOLOGY<\/strong><\/h3>\n

Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications<\/strong><\/a>
Jun 16, 2023 | Gaonkar RH et al.
IGG100<\/a> used for radiolabeling of CXCR4-targeting radioligands with [68<\/sup>Ga]Gallium<\/p>\n

NETs<\/strong><\/h3>\n

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177<\/sup>Lu-DOTATATE<\/strong><\/a>
Apr 17, 2023 | Delbart W et al.
Modular-Lab PharmTracer<\/a> used for production of [177<\/sup>Lu]-DOTATATE<\/p>\n

Preclinical Evaluation of [155\/161<\/sup>Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours<\/a><\/strong>
Apr 01, 2023 | Wharton L et al.
AR-2000<\/a> used for TLC imaging of [155\/161<\/sup>Tb]Tb-Crown-TATE<\/p>\n

NEUROLOGY<\/strong><\/h3>\n

Time course of neuroinflammation after human stroke – a pilot study using co-registered PET and MRI<\/a><\/strong>
May 16, 2023 | D\u2019Anna L et al.
Modular-Lab<\/a> used for preparation of [11<\/sup>C]-PBR28<\/p>\n

Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-\u03b2 and tau<\/strong><\/a>
May 04, 2023 | Banka V et al.\u00a0
Flow-Count<\/span> used in HPLC analysis of [18<\/sup>F]SFB<\/p>\n

PNEUMOLOGY<\/strong><\/h3>\n

[68<\/sup>Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography<\/a><\/strong>
May 30, 2023 | Bendova K et al.
IGG100 <\/span>used for the preparation [68<\/sup>Ga]-ORNB<\/p>\n

Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc.<\/a><\/strong>
May 22, 2023 | Sung PS et al.
AR-2000<\/span> used for TLC analysis of 111<\/sup>In-labeled compounds<\/p>\n

Impaired alveolar macrophage 11\u03b2-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS<\/strong><\/a>
Apr 27, 2023 | Mahida RY et al.
AR-2000<\/span> used for TLC analysis of [3<\/sup>H] labeled compounds<\/p>\n

UROLOGY<\/strong><\/h3>\n

A prospective head-to-head comparison of [68<\/sup>Ga]Ga-P16-093 and [68<\/sup>Ga]Ga-PSMA-11 PET\/CT in patients with primary prostate cancer<\/strong><\/a>
May 26, 2023 | Wang G et al.
GalliaPharm\u00ae<\/sup><\/a> used to prepare [68<\/sup>Ga]-PSMA-11 and [68<\/sup>Ga]-P16-093<\/p>\n

68<\/sup>Ga-PSMA PET\/CT and Prostate Cancer Diagnosis: Which SUVmax Value?<\/a><\/strong>
May 03, 2023 | Pepe P et al.
Modular-Lab Pharmtracer<\/a> used for preparation of 68<\/sup>Ga-PSMA-11<\/p>\n

Treatment of Prostate Cancer with CD46-targeted 225<\/sup>Ac Alpha Particle Radioimmunotherapy<\/a><\/strong>
May 01, 2023 | Bidkar AP et al.
AR-2000<\/a> used for TLC analysis of [225<\/sup>Ac]DOTA-YS5<\/p>\n

OTHER \/ GENERAL<\/strong><\/h3>\n

Optimized production, purification, and radiolabeling of the 203<\/sup>Pb\/212<\/sup>Pb theranostic pair for nuclear medicine<\/strong><\/a>
Jun 30, 2023 | McNeil BL et al.
AR-2000<\/span> used for TLC analysis of 203<\/sup>Pb\/212<\/sup>Pb elutes<\/p>\n

Organelle interactions compartmentalize hepatic fatty acid trafficking and metabolism<\/a><\/strong>
Jun 19, 2023 | Najt CP et al.\u00a0
AR-2000<\/span> used for [14<\/sup>C]Carbon labeled compounds<\/p>\n

Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers<\/a><\/strong>
Jun 01, 2023 | d\u2018Orchymont F et al.
IGG100<\/span> used for the preparation [68<\/sup>Ga]Gallium labeled dual-modality imaging agents<\/p>\n

Optimization of 177<\/sup>Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application<\/strong><\/a>
May 26, 2023 | Cankaya A et al.\u00a0
[177<\/sup>Lu]Lutetium<\/a> and Modular-Lab eazy<\/a> used to radiolabel DOTA-TOC, PSMA-I&T and FAPI-46<\/p>\n

Visualizing Galectin-3 Binding Protein Expression with ImmunoPET<\/strong><\/a>
May 16, 2023 | Kein\u00e4nen O et al.
AR-2000<\/span> used for TLC analysis of [89<\/sup>Zr]Zirconium labeled compound<\/p>\n

Membrane-based microfluidic solvent extraction of Ga-68 from aqueous Zn solutions: towards an automated cyclotron production loop<\/strong><\/a>
May 05, 2023 | Trapp S et al.
IGG100<\/span> used in analysis of cyclotron-produced [68<\/sup>Ga]Gallium<\/p>\n

Radiolabeling, Quality Control, and Cell Binding Studies of New 99m<\/sup>Tc-Labeled Bisphosphonates: 99mTc-Ibandronate Sodium<\/strong><\/a>
May 01, 2023 | Ekinci M et al.\u00a0
AR-2000 <\/span>used for TLC analysis of [99m<\/sup>Tc]Tc-IBD<\/p>\n

Synthesis and Evaluation of Fluorine-18-Labeled L-Rhamnose Derivatives<\/strong><\/a>
Apr 27, 2023 | Zhang X et al.\u00a0
Flow-Count<\/span> used for HPLC analysis of [18<\/sup>F]-fluoro-L-rhamnose<\/p>\n

Cyclotron production of 43<\/sup>Sc and 44g<\/sup>Sc from enriched 42<\/sup>CaO, 43<\/sup>CaO, and 44<\/sup>CaO targets<\/strong><\/a>
Apr 26, 2023 | Becker KV et al.\u00a0
GalliaPharm\u00ae<\/sup><\/a> used to obtain [68<\/sup>Ga]Gallium for comparison with 43<\/sup>Sc and 44g<\/sup>Sc as PET candidates<\/p>\n

Radiometallation and photo-triggered release of ready-to-inject radiopharmaceuticals from the solid phase<\/a><\/strong>
Apr 17, 2023 | Smilowicz D et al.
IGG100<\/span> used for radiolabelling with [68<\/sup>Ga]Gallium<\/p>\n

131<\/sup>I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer<\/strong><\/a>
Apr 08, 2023 | Zhao L et al.
Flow-Count<\/span> used in HPLC analysis of [131<\/sup>I]-NM-02<\/p>\n\n\n

Want to see your publication here?<\/p>

If you would like to add your publication to one of the future iterations of \u201cIlluminating Innovation\u201d, make sure to contact us at marketing.medical@ezag.de<\/strong><\/p>\n <\/div>\n\t\n<\/section>\t\n\t\t\n\n\t\t<\/div>\n\t \t

\n \n
\n Marius W\u00f6lfges\n
\n Marius W\u00f6lfges<\/span>\n Marketing Manager<\/span>\n <\/div>\n <\/div>\n
\n
<\/div>\n <\/div>\n <\/div>
\n
\n

This could be interesting for people in your network?<\/p>\n

\n <\/a>\n <\/a>\n <\/a>\n <\/a>\n <\/div>\n <\/div>\n
\n